Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) were down 46.3% during trading on Tuesday . The stock traded as low as $0.50 and last traded at $0.50. Approximately 4,130 shares changed hands during mid-day trading, a decline of 54% from the average daily volume of 9,053 shares. The stock had previously closed at $0.93.
Peak Pharmaceuticals Price Performance
The firm’s 50-day moving average price is $1.65 and its 200 day moving average price is $2.37.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Read More
- Five stocks we like better than Peak Pharmaceuticals
- Best Stocks Under $5.00
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Profitably Trade Stocks at 52-Week Highs
- Netflix Is On Track To Hit $1,000 By Christmas
- How is Compound Interest Calculated?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
